Pascal Soriot, the 'sir' who went from the 'banlieue' to lead AstraZeneca
The CEO of the second most highly valued company on the UK stock exchange is back in the spotlight over a possible merger with BMS that has already been denied.
Pascal Soriot (Paris, France, 67 years old) learned to fight for his own in the neighborhood and in the mud. Brawls were common in the Parisian banlieue where he grew up, and until he was 16 he rolled up his sleeves in a good number of them. He has told the story again and again in interviews. It's not something he's proud of, but he says that sometimes you have to defend yourself and defend the group, a lesson he has drawn on at least once in the 14 years he has been at the helm of AstraZeneca.
This week, a punch published in the Financial Times has brought him back into the headlines . The British pharmaceutical company, the second most highly valued company on the UK stock market, and US Bristol Myers Squibb, according to the medium, had been negotiating a possible merger for months.
Translated by urgent.news. Machine-written — may contain errors; check the original before relying on it.
